Analysts said Medicare’s drug-price cuts were smaller or already reflected in forecasts. ・Pricing updates for major therapies ...

The U.S. District Court for the District of Columbia on Thursday rejected Teva Pharmaceuticals’ challenge to the Medicare ...

Wondering if Teva Pharmaceutical Industries is now a bargain or if you might be late to the party? You're not alone.

The discounts should be compared against the drugs’ “ultimate net price” rather than their indicated list price to gauge the ...

CMS’ newly released maximum fair prices include list-price reductions of 38% to 85% for 15 widely used medicines beginning in ...

The first of seven challenges for which Teva is seeking novel solutions revolves around human-predictive platforms for ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to deliver on the “Pivot to Growth” strategy CEO Richard Francis had envisioned ...

See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

The US District Court for the District of Columbia has rejected Israel-headquartered Teva Pharmaceuticals Industries’ ...

Teva gets a buy rating as it trades well below 10-year highs and shows growth potential as the leading global generic drugmaker. Their drug pipeline is robust and diverse, as well as existing drugs on ...

Teva Pharmaceuticals is recalling one lot of its injectable cancer drug topotecan after a pharmacy found one of the vials contained a glass particle. The FDA said July 1 that after a further ...

Calling him a “tremendous” health advocate, DeMyers adds that leveraging Davis to get the word out about TD will help more people start conversations with their doctors about the condition. Going ...